Accelerated phase I trial of targeted and tunable SARS-Cov-2 spike protein receptor binding domain recombinant protein and mRNA vaccines

  • Nolan, Terry (Primary Chief Investigator (PCI))
  • Godfrey, Dale Ian (Chief Investigator (CI))
  • Purcell, Prof Damian (Chief Investigator (CI))
  • Pouton, Colin (Chief Investigator (CI))
  • Jackson, David (Chief Investigator (CI))
  • Simpson, Prof Julie (Chief Investigator (CI))
  • Steven Rockman, Assoc Prof (Chief Investigator (CI))
  • Braat, Miss Sabine (Chief Investigator (CI))
  • Ratnam, Dr Irani (Chief Investigator (CI))

Project: Research

Project Details

Project Description

MRFF application funded in the following round: 2020 Rare Cancers Rare Diseases and Unmet Need - COVID 19
Short titleAccelerated phase I trial of SARS-CoV-2 vaccines
StatusFinished
Effective start/end date1/09/21 → 30/08/23

Keywords

  • COVID-19
  • Vaccine
  • Clinical trial